Skip to main navigation Skip to search Skip to main content

Prophylaxis of malaria

  • Sheba Medical Center at Tel Hashomer

Research output: Contribution to journalReview articlepeer-review

29 Scopus citations

Abstract

Malaria prevention in travelers to endemic areas remains dependent principally on chemoprophylaxis. Although malaria chemoprophylaxis refers to all malaria species, a distinction should be drawn between falciparum malaria prophylaxis and the prophylaxis of the relapsing malaria species (vivax & ovale). While the emergence of drug resistant strains, as well as the costs and adverse reactions to medications, complicate falciparum prophylaxis use, there are virtually no drugs available for vivax prophylaxis, beside of primaquine. Based on traveler's malaria data, a revised recommendation for using chemoprophylaxis in low risk areas should be considered.

Original languageEnglish
Article numbere2012045
JournalMediterranean Journal of Hematology and Infectious Diseases
Volume4
Issue number1
DOIs
StatePublished - 2012
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Prophylaxis of malaria'. Together they form a unique fingerprint.

Cite this